Australian biotech market today 18.03.09
Wednesday, 18 March, 2009
Pharma and biotech stocks were down slightly at 2.30pm today, on an up-and-down day for the All Ords.
Alchemia (ASX:ACL) is up yet again on the market today, trading at 32c and still basking in the washout from its partner filing a new drug application for generic fondaparinux.
Avexa (ASX:AVX) is down a touch from its recent gains, Biota (ASX:BTA) is up 5c to 61c and Cytopia (ASX:CYT) is up a cent.
Cochlear (ASX:COH) keeps rising and is now trading over $50 while CSL (ASX:CSL) is down a bit.
Newly listed Genera Biosystems (ASX:GBI) is active, up 2c, as is Halcygen (ASX:HGN).
Mesoblast (ASX:MSB) is down 2c, while Nanosonics (ASX:NAN) is up.
Universal Biosensors (ASX:UBI) is up 5c.
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
